Genome-wide mechanisms of Smad binding

M Morikawa1, D Koinuma, K Miyazono

  • 1Ludwig Institute for Cancer Research, Science for Life Laboratory, Uppsala University, Biomedical Center, Uppsala, Sweden.

Oncogene
|May 23, 2012
PubMed

Insights

Transforming growth factor β (TGF-β) has a dual role in cancer, but its mechanisms are unclear. This review explores Smad proteins and genome-wide analyses to understand TGF-β's complex cancer effects and find biomarkers.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genomics

Background:

  • Transforming growth factor β (TGF-β) exhibits a dual role in cancer, paradoxically suppressing or promoting tumor progression and metastasis.
  • The precise molecular underpinnings of TGF-β’s complex functions in cancer remain incompletely understood.

Purpose of the Study:

  • This review focuses on Smad proteins, the key mediators of TGF-β signaling pathways.
  • It aims to elucidate the cell-type-specific binding patterns and transcriptional regulatory mechanisms of Smad proteins.

Main Methods:

  • The review synthesizes findings from recent studies employing genome-wide analyses of Smad binding sites.
  • It discusses the application of these advanced genomic techniques in cancer research.

Main Results:

  • Recent genome-wide studies reveal intricate cell-type-specific binding patterns of Smad proteins.
  • These studies shed light on the complex transcriptional regulation governed by Smad proteins in different cellular contexts.

Conclusions:

  • Genome-wide analyses offer powerful tools for dissecting the intricate mechanisms of cancer progression.
  • These approaches hold significant promise for identifying novel biomarkers for cancer diagnosis, prognosis, and therapeutic strategies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form dimers that...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...